Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6588 | 1467 | 27.7 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
617 | 3 | ACUTE KIDNEY INJURY//CONTRAST INDUCED NEPHROPATHY//ACUTE RENAL FAILURE | 13883 |
1903 | 2 | CONTRAST INDUCED NEPHROPATHY//NEPHROGENIC SYSTEMIC FIBROSIS//CONTRAST MEDIA | 5913 |
6588 | 1 | NEPHROGENIC SYSTEMIC FIBROSIS//GADOLINIUM//NEPHROGENIC FIBROSING DERMOPATHY | 1467 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEPHROGENIC SYSTEMIC FIBROSIS | authKW | 3717537 | 15% | 84% | 213 |
2 | GADOLINIUM | authKW | 1081641 | 26% | 13% | 388 |
3 | NEPHROGENIC FIBROSING DERMOPATHY | authKW | 1056580 | 4% | 89% | 57 |
4 | GADODIAMIDE | authKW | 684521 | 3% | 67% | 49 |
5 | GADOLINIUM BASED CONTRAST AGENTS | authKW | 610789 | 3% | 65% | 45 |
6 | GADOBUTROL | authKW | 405043 | 3% | 45% | 43 |
7 | GADOTERIDOL | authKW | 278124 | 1% | 64% | 21 |
8 | NEPHROGENIC SYSTEMIC FIBROSIS NSF | authKW | 275465 | 1% | 88% | 15 |
9 | GADOBENATE DIMEGLUMINE | authKW | 247265 | 3% | 30% | 39 |
10 | GADOVERSETAMIDE | authKW | 228945 | 1% | 100% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Radiology, Nuclear Medicine & Medical Imaging | 35219 | 59% | 0% | 872 |
2 | Neuroimaging | 3940 | 7% | 0% | 96 |
3 | Dermatology | 982 | 7% | 0% | 98 |
4 | Urology & Nephrology | 904 | 8% | 0% | 116 |
5 | Clinical Neurology | 400 | 9% | 0% | 127 |
6 | Transplantation | 116 | 2% | 0% | 33 |
7 | Rheumatology | 70 | 2% | 0% | 23 |
8 | Pathology | 39 | 2% | 0% | 32 |
9 | Medical Laboratory Technology | 37 | 1% | 0% | 16 |
10 | Pediatrics | 34 | 3% | 0% | 40 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GLOBAL MED REGULATORY AFFAIRS | 113313 | 0% | 78% | 7 |
2 | SCOTT WHITE CLIN HOSP | 67126 | 1% | 32% | 10 |
3 | GLOBAL CLIN DEV DIAGNOST IMAGING | 46828 | 0% | 75% | 3 |
4 | MED CLIN AFFAIRS RADIOL | 41626 | 0% | 100% | 2 |
5 | TRG DIAGNOST IMAGING | 37160 | 0% | 36% | 5 |
6 | MED NEPHROL 3 | 27750 | 0% | 67% | 2 |
7 | DIAGNOST RADIOL 54E2 | 24966 | 0% | 20% | 6 |
8 | ZENT BILDGEBENDE DIAGNOST | 23781 | 0% | 29% | 4 |
9 | MED AFFAIRS EUROPE | 22615 | 0% | 22% | 5 |
10 | GLOBAL MED AFFAIRS DIAGNOST IMAGING | 22195 | 0% | 27% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INVESTIGATIVE RADIOLOGY | 108429 | 11% | 3% | 160 |
2 | JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING | 10141 | 1% | 4% | 13 |
3 | JOURNAL OF MAGNETIC RESONANCE IMAGING | 9994 | 4% | 1% | 55 |
4 | RADIOLOGY | 8550 | 6% | 0% | 89 |
5 | AMERICAN JOURNAL OF NEURORADIOLOGY | 7918 | 4% | 1% | 64 |
6 | EUROPEAN RADIOLOGY | 7445 | 4% | 1% | 53 |
7 | EUROPEAN JOURNAL OF RADIOLOGY | 3764 | 2% | 1% | 35 |
8 | MAGNETIC RESONANCE IMAGING | 3755 | 2% | 1% | 29 |
9 | ACADEMIC RADIOLOGY | 3328 | 2% | 1% | 25 |
10 | JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY | 3277 | 2% | 0% | 34 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEPHROGENIC SYSTEMIC FIBROSIS | 3717537 | 15% | 84% | 213 | Search NEPHROGENIC+SYSTEMIC+FIBROSIS | Search NEPHROGENIC+SYSTEMIC+FIBROSIS |
2 | GADOLINIUM | 1081641 | 26% | 13% | 388 | Search GADOLINIUM | Search GADOLINIUM |
3 | NEPHROGENIC FIBROSING DERMOPATHY | 1056580 | 4% | 89% | 57 | Search NEPHROGENIC+FIBROSING+DERMOPATHY | Search NEPHROGENIC+FIBROSING+DERMOPATHY |
4 | GADODIAMIDE | 684521 | 3% | 67% | 49 | Search GADODIAMIDE | Search GADODIAMIDE |
5 | GADOLINIUM BASED CONTRAST AGENTS | 610789 | 3% | 65% | 45 | Search GADOLINIUM+BASED+CONTRAST+AGENTS | Search GADOLINIUM+BASED+CONTRAST+AGENTS |
6 | GADOBUTROL | 405043 | 3% | 45% | 43 | Search GADOBUTROL | Search GADOBUTROL |
7 | GADOTERIDOL | 278124 | 1% | 64% | 21 | Search GADOTERIDOL | Search GADOTERIDOL |
8 | NEPHROGENIC SYSTEMIC FIBROSIS NSF | 275465 | 1% | 88% | 15 | Search NEPHROGENIC+SYSTEMIC+FIBROSIS+NSF | Search NEPHROGENIC+SYSTEMIC+FIBROSIS+NSF |
9 | GADOBENATE DIMEGLUMINE | 247265 | 3% | 30% | 39 | Search GADOBENATE+DIMEGLUMINE | Search GADOBENATE+DIMEGLUMINE |
10 | GADOVERSETAMIDE | 228945 | 1% | 100% | 11 | Search GADOVERSETAMIDE | Search GADOVERSETAMIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TODD, DJ , KAY, J , (2016) GADOLINIUM-INDUCED FIBROSIS.ANNUAL REVIEW OF MEDICINE, VOL 67. VOL. 67. ISSUE . P. 273 -291 | 83 | 93% | 5 |
2 | ZOU, ZT , ZHANG, HL , RODITI, GH , LEINER, T , KUCHARCZYK, W , PRINCE, MR , (2011) NEPHROGENIC SYSTEMIC FIBROSIS REVIEW OF 370 BIOPSY-CONFIRMED CASES.JACC-CARDIOVASCULAR IMAGING. VOL. 4. ISSUE 11. P. 1206 -1216 | 99 | 96% | 33 |
3 | RAMALHO, J , SEMELKA, RC , RAMALHO, M , NUNES, RH , ALOBAIDY, M , CASTILLO, M , (2016) GADOLINIUM-BASED CONTRAST AGENT ACCUMULATION AND TOXICITY: AN UPDATE.AMERICAN JOURNAL OF NEURORADIOLOGY. VOL. 37. ISSUE 7. P. 1192 -1198 | 55 | 89% | 9 |
4 | IDEE, JM , FRETELLIER, N , ROBIC, C , COROT, C , (2014) THE ROLE OF GADOLINIUM CHELATES IN THE MECHANISM OF NEPHROGENIC SYSTEMIC FIBROSIS: A CRITICAL UPDATE.CRITICAL REVIEWS IN TOXICOLOGY. VOL. 44. ISSUE 10. P. 895 -913 | 95 | 75% | 14 |
5 | ABU-ALFA, AK , (2011) NEPHROGENIC SYSTEMIC FIBROSIS AND GADOLINIUM-BASED CONTRAST AGENTS.ADVANCES IN CHRONIC KIDNEY DISEASE. VOL. 18. ISSUE 3. P. 188-198 | 84 | 92% | 26 |
6 | BERNSTEIN, EJ , SCHMIDT-LAUBER, C , KAY, J , (2012) NEPHROGENIC SYSTEMIC FIBROSIS: A SYSTEMIC FIBROSING DISEASE RESULTING FROM GADOLINIUM EXPOSURE.BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. VOL. 26. ISSUE 4. P. 489-503 | 78 | 95% | 23 |
7 | MAZHAR, SM , SHIEHMORTEZA, M , KOHL, CA , MIDDLETON, MS , SIRLIN, CB , (2009) NEPHROGENIC SYSTEMIC FIBROSIS IN LIVER DISEASE: A SYSTEMATIC REVIEW.JOURNAL OF MAGNETIC RESONANCE IMAGING. VOL. 30. ISSUE 6. P. 1313-1322 | 83 | 100% | 10 |
8 | BESHELI, LD , ARAN, S , SHAQDAN, K , KAY, J , ABUJUDEH, H , (2014) CURRENT STATUS OF NEPHROGENIC SYSTEMIC FIBROSIS.CLINICAL RADIOLOGY. VOL. 69. ISSUE 7. P. 661-668 | 63 | 98% | 22 |
9 | WELLER, A , BARBER, JL , OLSEN, OE , (2014) GADOLINIUM AND NEPHROGENIC SYSTEMIC FIBROSIS: AN UPDATE.PEDIATRIC NEPHROLOGY. VOL. 29. ISSUE 10. P. 1927 -1937 | 68 | 91% | 9 |
10 | PRINCE, MR , ZHANG, HL , RODITI, GH , LEINER, T , KUCHARCZYK, W , (2009) RISK FACTORS FOR NSF: A LITERATURE REVIEW.JOURNAL OF MAGNETIC RESONANCE IMAGING. VOL. 30. ISSUE 6. P. 1298-1308 | 78 | 84% | 53 |
Classes with closest relation at Level 1 |